Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 8Lymphoid 3CNS 3Other hematologic neoplasm 2Other 2Head & Neck 2Genitourinary 2Gastrointestinal 2Thoracic 1Plasma cell 1

Conditions

Brain Neoplasms 264Glioblastoma 245Glioma 187Neuroblastoma 83Neoplasms 58Central Nervous System Neoplasms 53Astrocytoma 53Medulloblastoma 45Breast Neoplasms 42Sarcoma 38Melanoma 38Carcinoma, Non-Small-Cell Lung 37Neurofibromatosis 1 36Meningioma 35Ependymoma 35Lung Neoplasms 34Osteosarcoma 29Rhabdomyosarcoma 28Diffuse Intrinsic Pontine Glioma 27Sarcoma, Ewing 26Recurrence 26Rhabdoid Tumor 25Neoplasm Metastasis 25Oligodendroglioma 22Wilms Tumor 21Gliosarcoma 21Pancreatic Neoplasms 20Pheochromocytoma 19Hepatoblastoma 19Thyroid Neoplasms 18

Interventions

Remifentanil 1Methadone 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Pain × CNS × 90 days × Clear all
NCT06507748 2026-06-05

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

National Institutes of Health Clinical Center (CC)

Phase NA Recruiting
70 enrolled
CNS

Neurofibromatosis 1, Pain, Neurofibroma, Plexiform

NCT01362803 2026-06-01

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
99 enrolled 1 FDA
CNS

Neurofibromatosis 1, Pain, Neurofibroma, Plexiform

NCT06810336 2026-05-04

Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery

University of Virginia

Phase EARLY_PHASE1 Recruiting
40 enrolled
CNS

Brain Injuries, Brain Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡